Skip to main content
Esoteric Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Canada - Size and Forecast 2024-2028

Esoteric Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Canada - Size and Forecast 2024-2028

Published: Aug 2024 164 Pages SKU: IRTNTR76289

Market Overview at a Glance

$25.84 B
Market Opportunity
13.64%
CAGR
11.73
YoY growth 2023-2024(%)

Esoteric Testing Market Size 2024-2028

The global esoteric testing market size is estimated to grow by USD 25.84 billion at a CAGR of 13.64% between 2023 and 2028. The market's growth is influenced by several key factors, including the rising incidence of chronic diseases, an uptick in new product introductions, and a surge in merger and acquisition endeavors. As chronic conditions become more prevalent, there's a growing need for innovative healthcare solutions to address these challenges. The influx of new products entering the market reflects a dynamic landscape driven by technological advancements and evolving consumer preferences. Additionally, the uptick in merger and acquisition activities indicates a trend toward consolidation and strategic partnerships aimed at enhancing market presence and competitiveness. These factors collectively contribute to the market's growth trajectory, shaping the future of healthcare delivery and patient outcomes.

Esoteric tests are useful in the early detection of chronic diseases. Chronic diseases are one of the leading causes of disability and death worldwide. The three main chronic diseases are cardiovascular disease, chronic obstructive pulmonary disease (COPD), and type 2 diabetes, often caused by high blood pressure (BP), blood cholesterol, and obesity. In addition, chronic diseases such as heart disease, asthma, cancer, and diabetes are generally not curable. These diseases can indeed be prevented and controlled through various measures, including exercise, a healthy diet, and early detection and treatment. Additionally, managed care organizations play a role in providing comprehensive care, and technologies like real-time PCR can aid in early detection. Expanded care delivery models also play a crucial role in ensuring access to preventive and treatment services. These diseases are diagnosed in a clinical laboratory. Hence, the increasing prevalence of chronic diseases will drive the growth of the market during the forecast period.

What will be the Size of the Market During the Forecast Period?

Esoteric Testing Market Size

To learn more about this report, Request Free Sample

Market Segmentation

End User Analysis

The market share growth by the Endocrinology  segment will be significant during the forecast period.  This market caters to the diagnosis and management of Rare genetic disorders, Immunology Testing, Genetic Testing, Endocrinology tests, Oncology tests, and Toxicology Testing. With the increasing number of Cancer cases, there is a growing demand for these tests to aid in disease diagnosis, prognosis, and therapeutic treatment. The clinical laboratory industry relies on complex apparatus and trained personnel to handle Rare molecules and deliver Expanded care delivery.

Esoteric Testing Market Size

Get a glance at the market contribution of various segments View a PDF Sample

The Endocrinology segment was valued at USD 3.88 billion in 2018. The market for these tests is driven by the growing healthcare expenditure and the shift towards Personalised medicine using Sophisticated chemicals. Key areas of focus include Neurology Testing and the development of new diagnostic tools for various diseases.

By Region

Esoteric Testing Market Share by Geography

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Factors such as the adoption of advanced technologies coupled with a well-established healthcare infrastructure will drive the growth of the market in the region. Several hospitals and clinics in the area are adopting esoteric testing services to effectively diagnose and treat a rapidly growing number of patients.

Furthermore, the growing number of corporate wellness programs and travel and tourism activities are driving the growth of the market. In the US, many organizations offer healthcare as part of their corporate wellness program, which is increasing the adoption of clinical laboratory services. The growing demand for esoteric tests from government organizations for procedures like visa approval is also driving the growth of the market. Hence, such factors are expected to drive market growth in this region during the forecast period.

Buy Now Full Report and Discover More

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

The University of Utah:  The company offers esoteric testing, such as in-house esoteric testing panels, under the lab called ARUP Laboratories.

  • ATS GENETECH PVT. LTD.
  • Bio Rad Laboratories Inc.
  • Creative Biogene
  • Cytek Biosciences Inc.
  • EMSL Analytical Inc.
  • Enzo Biochem Inc.
  • Intertek Group Plc
  • IQVIA Holdings Inc.
  • Kindstar Globalgene Technology Inc.
  • Laboratory Corp. of America Holdings
  • Machaon Diagnostics Inc.
  • MedGenome Labs Ltd.
  • Merck KGaA
  • Microbac Laboratories Inc.
  • Miltenyi Biotec B.V. and Co. KG
  • Oncquest Laboratories Ltd.
  • Rochester Regional Health
  • Sonic Healthcare Ltd.
  • Yoda Diagnostics

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

Esoteric testing plays a crucial role in precision medicines by enabling early diagnosis of various conditions, including cardiovascular diseases, Dengue, Hepatitis B, Hepatitis C, and rare genetic disorders. This type of testing often involves advanced techniques such as mass spectrometry, enzyme-linked immunosorbent assay, real-time polymerase chain reaction, and multiplexing to analyze hormones, proteins, antibodies, nucleic acids, and other rare molecules. Due to its complexity, esoteric testing requires complex apparatus and trained personnel to perform tests accurately and efficiently. It is commonly used in immunology testing, genetic testing, endocrinology tests, oncology tests, toxicology testing, and neurology testing to provide valuable insights for patient care. Our researchers analyzed the data with 2023 as the base year, along with the key trends and challenges. 

Significant Market Trends

Growing emphasis on expansions of esoteric testing facilities is a primary trend in the market. An increase in the global average age due to an increase in longevity or life expectancy will lead to an increase in the number of elderly people in the world. In addition, advances in medicine and healthcare have resulted in fewer cases of disability. The increase in the elderly population has led to an increase in healthcare costs related to regular health check-ups, disease diagnosis, treatment, and surgery.

Furthermore, the most common problems affecting the aging population are Alzheimer's disease (AD), cardiovascular disease, osteoarthritis, diabetes, and cancer. Since the elderly have weak immunity and metabolism, they need frequent diagnostic testing. This increases the demand for esoteric testing services. As a result, the growing aging population globally, especially in countries like Japan and Italy, will boost the growth of the market during the forecast period.

Major Market Challenges

The lack of skilled clinical laboratory professionals is a challenge that affects the growth of the market. Clinical laboratory specialists are trained and certified professionals who are trained in the theoretical and practical aspects of clinical laboratory processes and procedures. Clinical laboratory professionals play different roles, such as technologists, research technologists, supervisors, administrators, or educators. Approximately 60-70% of all medical decisions regarding admission and discharge, as well as diagnosis and treatment, are determined by the relevant tests and diagnoses performed by laboratory specialists. 

However, there is still a shortage of trained professionals who can handle advanced diagnostic equipment. Lack of expertise increases the likelihood of misdiagnosis. Therefore, it is important to train staff in the use of critical diagnostic equipment. The market is very competitive. Therefore, an accurate diagnosis is essential. Hence, the lack of skilled technicians and lab professionals may impede the growth of the market during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Esoteric Testing Market Share by Geography

Market Customer Landscape

Segment Overview

The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

  • Type Outlook 
    • Infectious disease
    • Endocrinology
    • Oncology
    • Immunology
    • Others
  • End-user Outlook 
    • Hospital laboratories
    • Clinical research laboratories and medical institutes
    • Reference laboratories
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World
      • Australia
      • Argentina
      • Brazil 

You may also interested in below market reports:

Clinical Laboratory Services Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, China, Germany, Japan - Size and Forecast

In-vitro Diagnostics (IVD) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, China, Japan - Size and Forecast

Hepatitis B and C Diagnostics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, China - Size and Forecast

Market Analyst Overview

The market is critical for diagnosing and monitoring complex diseases such as HIV, Malaria, and Tuberculosis. Advanced technologies like DNA sequencing and NGS technologies, including whole genome sequencing, enable precise analysis. Reimbursement from Medicare, Medicaid, and managed care organizations supports access to these tests. Biomarker analysis using techniques like digital PCR, pyrosequencing, and Sanger sequencing aids in disease detection. Digital microfluidic platforms and molecular phenotyping technologies provide insights for personalized medicine. With an aging population, demand for endocrinology and oncology tests is rising, necessitating chemiluminescence immunoassay, flow cytometry, and real-time PCR for accurate results and improved patient care.

Market Scope

Report Coverage

Details

Page number

164

Base year

2023

Historic period

2018 - 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 13.64%

Market growth 2024-2028

USD 25.84 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

11.73

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key countries

US, Germany, UK, China, and Canada

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

ATS GENETECH PVT. LTD., Bio Rad Laboratories Inc., Creative Biogene, Cytek Biosciences Inc., EMSL Analytical Inc., Enzo Biochem Inc., Intertek Group Plc, IQVIA Holdings Inc., Kindstar Globalgene Technology Inc., Laboratory Corp. of America Holdings, Machaon Diagnostics Inc., MedGenome Labs Ltd., Merck KGaA, Microbac Laboratories Inc., Miltenyi Biotec B.V. and Co. KG, Oncquest Laboratories Ltd., Rochester Regional Health, Sonic Healthcare Ltd., The University of Utah, and Yoda Diagnostics

Market dynamics

Parent market analysis, Market forecasting , market forecast , Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2028.
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Esoteric Testing market growth will increase by $ 25838.5 mn during 2024-2028.

The Esoteric Testing market is expected to grow at a CAGR of 13.64% during 2024-2028.

Esoteric Testing market is segmented by Type( Endocrinology, Oncology, Immunology, Others, Others) End-user( Hospital laboratories, Clinical research laboratories and medical institutes, Reference laboratories)

ATS GENETECH PVT. LTD., Bio Rad Laboratories Inc., Creative Biogene, Cytek Biosciences Inc., EMSL Analytical Inc., Enzo Biochem Inc., Intertek Group Plc, IQVIA Holdings Inc., Kindstar Globalgene Technology Inc., Laboratory Corp. of America Holdings, Machaon Diagnostics Inc., MedGenome Labs Ltd., Merck KGaA, Microbac Laboratories Inc., Miltenyi Biotec B.V. and Co. KG, Oncquest Laboratories Ltd., Rochester Regional Health, Sonic Healthcare Ltd., The University of Utah, Yoda Diagnostics are a few of the key vendors in the Esoteric Testing market.

North America will register the highest growth rate of 39% among the other regions. Therefore, the Esoteric Testing market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Germany, UK, China, Canada

  • Increasing prevalence of chronic diseasesChronic diseases are one of the major causes of disabilities and death across the world. The three major chronic diseases are CVD is the driving factor this market.
  • chronic obstructive pulmonary disease (COPD) is the driving factor this market.
  • and type-2 diabetes is the driving factor this market.
  • which are commonly caused due to high blood pressure (BP) is the driving factor this market.
  • blood cholesterol is the driving factor this market.
  • and obesity. Unhealthy diets is the driving factor this market.
  • a lack of physical activity is the driving factor this market.
  • and tobacco use can also cause chronic diseases like CVD and diabetes. By 2021 is the driving factor this market.
  • chronic diseases are expected to cause more than 70% of all deaths and more than 60% of the global burden of diseases. Chronic diseases is the driving factor this market.
  • such as hypertension is the driving factor this market.
  • are also known as silent killers is the driving factor this market.
  • as they often have no warning signs or symptoms. Many people are unaware that they have high BP. The global prevalence of hypertension is expected to increase significantly by 2024. The prevalence of hypertension is high in low- and middle-income countries. The complications of hypertension are responsible for approximately 55% of all cardiovascular-related deaths globally every year. The major risk factors for hypertension include diabetes is the driving factor this market.
  • obesity is the driving factor this market.
  • family history of high BP is the driving factor this market.
  • old age is the driving factor this market.
  • chronic kidney disease is the driving factor this market.
  • high sodium intake is the driving factor this market.
  • a sedentary lifestyle is the driving factor this market.
  • stress is the driving factor this market.
  • and alcohol addiction. The prevalence of diabetes and obesity is expected to increase rapidly in the next decade due to the rising number of people adopting a sedentary lifestyle. Chronic diseases such as heart disease is the driving factor this market.
  • asthma is the driving factor this market.
  • cancer is the driving factor this market.
  • and diabetes are usually incurable. These diseases can be prevented and managed through exercise is the driving factor this market.
  • a healthy diet is the driving factor this market.
  • and early detection and treatment. These diseases are diagnosed in clinical laboratories. Hence is the driving factor this market.
  • the growing prevalence of chronic diseases will drive the growth of the global esoteric testing market during the forecast period. is the driving factor this market.

The Esoteric Testing market vendors should focus on grabbing business opportunities from the Endocrinology segment as it accounted for the largest market share in the base year.